Cardiovascular risks of chemo-immunotherapy for lung cancer: A population-based cohort study-Reference-Cited by-同舟云学术

Cardiovascular risks of chemo-immunotherapy for lung cancer: A population-based cohort study

Published:2022-12 Issue: Volume:174 Page:67-70
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chan Jeffrey Shi Kai,Tang Pias,Ng Kenrick,Dee Edward Christopher,Lee Teddy Tai Loy,Chou Oscar Hou In,Lee Yan Hiu Athena,Lau Dawnie Ho Hei,Liu Tong,Tse Gary

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference10 articles.

1. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer;Gandhi;N. Engl. J. Med.,2018

2. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer;Reck;N. Engl. J. Med.,2016

3. Cardiovascular Health during and after Cancer Therapy;Ruddy;Cancers,2020

4. M.F. Tsoi, M.H. Chung, B.M.Y. Cheung, C.S. Lau, T.T. Cheung, Epidemiology of gout in Hong Kong: A population-based study from 2006 to 2016, Arthritis Res. Ther. 22 (2020) 1–9. doi: 10.1186/S13075-020-02299-5/FIGURES/5.

5. Cardiovascular outcomes and hospitalizations in Asian patients receiving immune checkpoint inhibitors: a population-based study;Chan;Curr. Probl. Cardiol.,2023

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis;Cancer Innovation;2024-04-15

2. Cardiovascular health of patients with cancer: Challenges abound;Trends in Cardiovascular Medicine;2024-04

3. Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers;Journal of Advanced Research;2024-03

4. Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin‐induced myocardial injury;Cancer Innovation;2023-03-30

5. Editorial: Novel phenotyping and risk stratification strategies for heart failure;Frontiers in Cardiovascular Medicine;2023-01-05